Melanoma/Skin Cancer

Top Story

Topical imiquimod may be effective alternative to surgery for melanoma in situ

April 25, 2017

Topical imiquimod cream may be an effective treatment for patients with melanoma in situ who are not candidates for surgery, according to long-term study outcomes published in Dermatologic Surgery.

Researchers conducted a retrospective chart review of 12 white patients with biopsy-proven melanoma in situ (seven men; average age, 79 years) who were treated with topical 5% imiquimod cream between 2004 and 2015 at the dermatology section of Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

FDA News

FDA issues warnings about fraudulent cancer treatments

April 25, 2017
The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or cure cancer. The…
Meeting NewsVideo

VIDEO: Key takeaways from HemOnc Today Melanoma and Cutaneous Malignancies

April 20, 2017
NEW YORK — Sanjiv S. Agarwala, MD, program director for HemOnc Today Melanoma and Cutaneous Malignancies, provided an overview of key takeaway messages from the…

Medical groups support March for Science

April 19, 2017
More than two dozen of the world’s leading medical and scientific organizations pledged their support for this weekend’s March for Science. The march will be…
CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately…
More »
Video
Meeting News

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma

April 9, 2017
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
In the Journals

Topical imiquimod may be effective alternative to surgery for melanoma in situ

April 25, 2017
Topical imiquimod cream may be an effective treatment for patients with melanoma in situ who are not candidates for surgery, according to long-term…

FDA News

FDA issues warnings about fraudulent cancer treatments

April 25, 2017
The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or…

Meeting NewsVideo

VIDEO: Key takeaways from HemOnc Today Melanoma and Cutaneous Malignancies

April 20, 2017
NEW YORK — Sanjiv S. Agarwala, MD, program director for HemOnc Today Melanoma and Cutaneous Malignancies, provided an overview of key takeaway…

Medical groups support March for Science

April 19, 2017
More than two dozen of the world’s leading medical and scientific organizations pledged their support for this weekend’s March for…

Meeting NewsVideo

VIDEO: Speaker discusses targeted treatment for melanoma

April 19, 2017
NEW YORK — Jeffrey A. Sosman, MD, offered updates in the treatment of BRAF V600–mutant melanoma in light of greater use of immunotherapy…

Technology appears ‘on par’ with dermatologists for identification of benign, malignant skin lesions

April 18, 2017
A deep convolutional neural network developed by researchers at Stanford University effectively identified and diagnosed benign and malignant skin…

In the Journals Plus

Men with HIV, nonmelanoma skin cancer at greater risk for Kaposi’s sarcoma

April 18, 2017
Men with HIV and nonmelanoma skin cancer faced an elevated risk for Kaposi’s sarcoma, as did men with HIV who lived in locations with high

Meeting NewsVideo

VIDEO: Speaker offers updates in cutaneous squamous cell carcinoma

April 16, 2017
NEW YORK — Axel Hauschild, MD, professor of dermatology and head of dermato-oncology at University Hospital in Kiel, Germany, provided an…

Meeting NewsVideo

VIDEO: Speaker reviews pros, cons of combining targeted therapy, immunotherapy for melanoma

April 15, 2017
NEW YORK — Jason J. Luke, MD, FACP, assistant professor of medicine at University of Chicago, spoke at HemOnc Today Melanoma and Cutaneous…

Meeting News

Ten takeaways from the AACR Annual Meeting

April 14, 2017
This year’s American Association for Cancer Research Annual Meeting — titled “Research Propelling Cancer Prevention and…

More Headlines »
Advertisement
Advertisement